ArticleCureus2026
Effectiveness of a Five-Day Multimodal Intensive Treatment Program for Obsessive-Compulsive Disorder: A Prospective Observational Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionObsessive-compulsive disorder (OCD) is a chronic psychiatric disorder that frequently requires a combination of pharmacological and behavioral interventions. Intensive treatment programs integrating optimized pharmacotherapy, exposure and response prevention (ERP), and neuromodulation have emerged as promising approaches for accelerating symptom improvement. However, evidence regarding the effectiveness of complete adherence to such multimodal interventions in routine clinical practice remains limited. This study evaluated the clinical effectiveness and safety of a five-day multimodal intensive treatment program in patients with OCD. MATERIALS AND
methodsThis prospective observational study included 123 adults with OCD enrolled in a standardized five-day intensive outpatient program. The participants received optimized pharmacotherapy, therapist-guided ERP, and adjunctive neuromodulation using repetitive transcranial magnetic stimulation or transcranial direct current stimulation. Based on treatment adherence, participants were categorized into full (n = 45) and partial (n = 78) triad groups. The primary outcome was the change in Obsessive-Compulsive Inventory (OCI) scores from baseline to Day 5 and four-week follow-up. Secondary outcomes included treatment adherence characteristics and treatment-related adverse events. Independent-samples t-tests, chi-square tests, or Fisher's exact tests, as appropriate, were used for between-group comparisons, while analysis of covariance (ANCOVA) was performed to compare Week-4 Yale-Brown Obsessive Compulsive Scale (Y-BOCS) scores after adjustment for baseline Y-BOCS score and age. Statistical significance was set at p < 0.05.
resultsThe two groups were similar in baseline clinical and demographic features. The full triad group demonstrated significantly greater reductions in OCI scores than the partial triad group at both the five- and four-week follow-up (both p < 0.001). Participants with complete adherence also completed significantly more ERP and neuromodulation sessions and showed higher homework compliance (all p < 0.001). After adjusting for baseline OCI score and age, treatment adherence remained an independent predictor of Week-4 OCI outcomes (p < 0.001). There were no appreciable variations in treatment-related complications, and the frequency of adverse events was similar among the groups.
conclusionsA five-day multimodal intensive treatment program combining optimized pharmacotherapy, ERP, and neuromodulation was associated with significant short-term improvements in OCD symptoms and demonstrated a favorable safety profile. Complete adherence to all treatment components is associated with superior clinical outcomes, highlighting the importance of comprehensive participation in intensive multimodal treatment programs for OCD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.